Loss of SMARCB1 evokes targetable epigenetic vulnerabilities in epithelioid sarcoma No … ← Andexanet alfa in patients with factor Xa inhibitor associated intracranial hemorrhage: the prospective observational multicenter ASTRO-DE study A single droplet dispensing system for high-throughput screening and reliable recovery of rare events →